Investors in Metagenomi, Inc. Face Potential Class Action Lawsuit

LOS ANGELES, Oct. 15, 2024 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) is reaching out to investors who have experienced significant losses and may want to take the lead in a class action lawsuit against Metagenomi, Inc. (“Metagenomi” or the “Company”) MGX.

Class Period: February 2024 IPO
Lead Plaintiff Deadline: November 25, 2024

Interested parties can register as lead plaintiff by providing their contact information at www.glancylaw.com/cases/Metagenomi-Inc/. For more information, reach out to Charles H. Linehan at GPM via phone at 310-201-9150, toll-free at 888-773-9224, or email at shareholders@glancylaw.com.

The lawsuit claims that during the Class Period, the Defendants failed to inform investors that: (1) Metagenomi’s collaboration with Moderna was set to end soon, instead of continuing; and (2) thus, the positive remarks made about the Company’s business, operations, and outlook were misleading and not based on accurate information.

For updates, follow us on LinkedIn, Twitter, or Facebook.

To participate in the class action, no immediate action is required. Investors can choose their own attorney or remain as absent class members. For further inquiries regarding this lawsuit and your rights, contact Charles Linehan, Esquire at GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067. You can also call 310-201-9150, toll-free at 888-773-9224, or email shareholders@glancylaw.com. Please include your mailing address, phone number, and number of shares purchased when inquiring by email.

This press release may be classified as Attorney Advertising in some regions according to relevant laws and ethical guidelines.

For More Information Contacts
Glancy Prongay & Murray LLP, Los Angeles
Charles Linehan, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/mgx-investors-have-opportunity-to-lead-metagenomi-inc-securities-fraud-lawsuit-302271173.html

SOURCE Glancy Prongay & Murray LLP